A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH)
Part of paid clinical trials in Chandler, Arizona.
- Sponsor
- Kriya Therapeutics, Inc.
- Study ID
- NCT07732400
- Phase
- PHASE1/PHASE2
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Metabolic Dysfunction-associated Steatohepatitis (MASH)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- VV-14303 — GENETICwill be administered via ultrasound guided intramuscular injections
Study Details
A Study of VV-14303 for the Treatment of Metabolic dysfunction-associated steatohepatitis (MASH)
Key Dates
- First listed
- Jul 28, 2026
- Start date
- Jul 31, 2026
- Status verified
- Jul 2026
- Primary completion
- Jul 31, 2028
- Completion
- Jul 31, 2029
Study Design
- Enrollment
- 56 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- TREATMENT
Arms
- Experimental: Part 1 Cohort 1, dose #1Dose #1 of VV-14303 will be administered
- Experimental: Part 1 Cohort 2, dose #2Dose #2 of VV-14303 will be administered
- Experimental: Part 1 Cohort 3, dose #3Dose #3 of VV-14303 will be administered
- Experimental: Part 2 doseVV-14303 will be administered at the dose determined from Part 1 (Cohorts 1, 2, and 3)
Primary Outcome Measure
Incidence and severity of adverse events, abnormal clinical laboratory values, abnormal physical exams, abnormal vital signs, abnormal ECGs, and abnormal imaging [ Time Frame: 52 Weeks ]
Central Contacts
- VP, Medical Affairs1.984.884.5058
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Kriya Clinical Trial Site | Chandler | Arizona | 85224 | |
| Kriya Clinical Trial Site | Lady Lake | Florida | 32159 | - |
Find similar trials in Chandler, AZ
Related Studies
- A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This ConditionPHASE2 · Recruiting · Regeneron Pharmaceuticals · Chandler, Arizona
- Fibrosis Lessens After Metabolic SurgeryPHASE4 · Recruiting · Ali Aminian · Phoenix, Arizona
- Evaluation of Miricorilant on Liver Fat in Patients With MASLDPHASE1 · Recruiting · Corcept Therapeutics · Columbia, Missouri
- Nutrition Intervention Combined With Resmetirom for MASHPHASE4 · Not Yet Recruiting · City University of New York · New York, New York